-
Awarded14/05/2025
-
Today22/06/2025
Utilities
- indicates text translated automatically in your browsing language
Pharmaceutical molecule - Propofol - co-entry Text automatically translated in your browsing language Automatically translated
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
The subject of the public contract is the continuous supply of the medicinal product ‘Propofol’ on the basis of the Framework Agreements on Commercial Cooperation, which will be concluded between the individual contracting entities – the persons involved in the joint procurement and the selected supplier according to the needs of the individual contracting entities, for a period of 24 months from the signing of the relevant Framework Agreement on Commercial Cooperation, including the transport of goods to their destination. Text automatically translated in your browsing language Automatically translated
Nemocnice Rudolfa a Stefanie Benešov, a.s., nemocnice Středočeského kraje
Oblastní nemocnice Mladá Boleslav, a.s., nemocnice Středočeského kraje
Oblastní nemocnice Kladno, a.s., nemocnice Středočeského kraje
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.